Research
First drug to treat Alexander disease approved by the FDA after three decades of research at UW–Madison
The drug is the first and only disease-modifying treatment for the rare neurological disease.
WARF announces total 2026 support for UW–Madison research
Last fiscal year, WARF provided $160.7 million in total support to UW–Madison and the Morgridge Institute for Research.
The U.S. National Science Foundation renews NSF IceCube operation and maintenance contract
The IceCube Neutrino Observatory, managed by UW–Madison, has secured $53 million in NSF funding through 2031.
Research Events
September
- 22
-
22
The physiology of Cyclospora and its impact on persistence in the environment and foods11:00 am, Online
-
22
LACIS Lunchtime Lecture Series
- 22
-
22
Pricing Climate Risk: Hurricane Models and Home Insurance Over the Last Two Decades
- 22
- 22